Mabylon AG

Mabylon AG

Biotechnology Research Schlieren-zurich, Ch 22 employees
Employees
22
Contacts
3
Emails
3
mabylon.com LinkedIn Crunchbase

Mabylon AG Overview

Headquarters
Schlieren-zurich, Ch
Website
mabylon.com
Industry
Biotechnology Research
Employees
22
Founded
2015
Funding
1.5M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Mabylon AG

Mabylon AG, a private Swiss biotech company, is leading innovation in antibody-based treatments for severe allergies, inflammation, and neurological disorders. Our B-cell screening platform rapidly identifies natural human antibodies with high specificity and therapeutic potential. MY006, our first-in-class multispecific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.

Mabylon AG Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage

Mabylon AG Org Chart

Sample employees and titles
Name Title Contact
Pascal G. Scientist, Phd in Immunology
View
Niccolo Pengo Chief Scientific Officer at Mabylon Ag
Email
Natascha Wuillemin Executive VP Immunology at Mabylon Ag
Email
Chiara Arena Senior Scientist Antibody Discovery
Email

Employees by Management Level

Associate / junior 5 profiles
Individual contributor 3 profiles
Executive 2 profiles
VP / Head 1 profile
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 5 5 0
Executive 1 1 0

Mabylon AG Tech Stack

Data / AI 2 profiles

Compare Similar Companies to Mabylon AG

Molecular Partners
Biotechnology Research
Biognosys
Biotechnology Research
CDR-Life Inc.
Biotechnology Research
Numab Therapeutics AG
Biotechnology Research
Neurimmune AG
Pharmaceutical Manufacturing
CUTISS AG
Biotechnology Research
Memo Therapeutics AG
Biotechnology Research
Athebio AG
Biotechnology
Araris Biotech AG
Biotechnology Research
ImmunOs Therapeutics AG
Biotechnology